Community-acquired pneumonia with risk for drug-resistant pathogens

Southern Medical Journal

Volumn 106, Issue 3, 2013, Pages 209-216

  Fleming, Virginia ^a   Buck, Brian ^a   Nix, Nancy ^a   Kumar, Parag ^a   Southwood, Robin ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; COMMUNITY ACQUIRED PNEUMONIA; COMMUNITY HOSPITAL; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; ICD-9; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; POPULATION RESEARCH; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; REVIEW;

EID: 84875027187     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318287fe71     Document Type: Review

References (29)

1. Hall MJ, DeFrances CJ, Williams SN, et al. National Health Statistics Reports. National Hospital Discharge Survey: 2007 summary. http://www.cdc.gov/ nchs/data/nhsr/nhsr029.pdf. Accessed August 29, 2011.
2. Xu J, Kochanek KD, Murphy SL, et al. Deaths: final data for 2007. http://www.cdc.gov/NCHS/data/nvsr/nvsr58/nvsr58-19.pdf. Accessed August 29, 2011.
3. Centers for Disease Control and Prevention, National Center for Health Statistics. Health data interactive. Mortality by underlying cause, ages 18+: US/state, 2001-2009. http://205.207.175.93/HDI/TableViewer/tableView.aspx? ReportId=673. Accessed October 19, 2012.
4. Centers for Disease Control and Prevention. National Center for Health Statistics. Health data interactive. Emergency department visits: US, 1995-2009. http://205.207.175.93/HDI/TableViewer/tableView.aspx? ReportId=113. Accessed July 20, 2011.
5. File TM, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgrad Med 2010;122:130-141.
6. Dean NC, Bateman KA, Donnelly SM, et al. Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. Chest 2006;130:794-799.
7. Capelastegui A, Espana PP, Quintana JM, et al. Improvement of processof-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study. Clin Infect Dis 2004;39:955-963.
8. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44:S27-S72.
9. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management, of adults with hospital-acquired, ventilatorassociated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
10. McCabe C, Kirchner C, Zhang HL, et al. Guideline-concordant therapy and reduced mortality and length of stay in adults with communityacquired pneumonia playing by the rules. Arch Intern Med 2009;169: 1525-1531.
11. Frei CR, Attridge RT, Mortensen EM, et al. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther 2010;32: 293-299.
12. Arnold FW, LaJoie AS, Brock GN, et al. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med 2009;169:1515-1524.
13. Grenier C, Pepin J, Nault V, et al. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and communityacquired pneumonia. J Antimicrob Chemother 2011;66:1617-1624.
14. Bratzler DW, Ma A, NsaW. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project. Clin Infect Dis 2008; 47:S193-S201.
15. Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med 2002;162:682-688.
16. Mortensen EM, Restrepo M, Anzueto A, et al. Effects of guidelineconcordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med 2004;117:726-731.
17. Mortensen EM, Restrepo MI, Anzueto A, et al. Antibiotic therapy and 48-hour mortality for patients with pneumonia. Am J Med 2006;119: 859-864.
18. Frei CR, Restrepo MI, Mortensen EM, et al. Impact of guidelineconcordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med 2006;119:865-871.
19. Asadi L, Eurich DT, Gamble JM, et al. Guideline adherence and macrolides reduced mortality in outpatients with pneumonia. Respir Med 2012;106:451-458.
20. Silveira CD, Ferreira CS, Correa R. Adherence to guidelines and its impact on outcomes in patients hospitalized with community-acquired pneumonia at a university hospital. J Bras Pneumol 2012;38:148-157.
21. Attridge RT, Frei CR, Restrepo MI, et al. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 2011;38: 878-887.
22. El Solh AA, Akinnusi ME, Alfarah Z, et al. Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing homeacquired pneumonia. J Am Geriatr Soc 2009;57:1030-1035.
23. Aliberti S, Di Pasquale M, Zanaboni AM, et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 2012;54:470-478.
24. Shorr AF, Zilberberg MD, Reichley R, et al. Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 2012;54: 193-198.
25. Madaras-Kelly KJ, Remington RE, Fan VS, et al. Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culturepositive patients with healthcare-associated pneumonia. J Hosp Med 2012;7:195-202.
26. Schreiber MP, Chan CM, Shorr AF. Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumoniä Chest 2010;137:1283-1288.
27. Labelle AJ, Arnold H, Reichley RM, et al. A comparison of culturepositive and culture-negative health-care-associated pneumonia. Chest 2010;137:1130-1137.
28. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000;31:347-382.
29. Shorr AF, Zilberberg MD, Micek ST, et al. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health careassociated pneumonia. Arch Inter Med 2008;168:2205-2210.